The new study, published in PLOS ONE, included registry data from nearly 4,500 patients. While COVID-19 patients faced a heightened risk of adverse cardiovascular outcomes early on, many of those risks faded after approximately one month.
AVS, a Michigan-based medical device company, has said the funding will help accelerate research on its new Pulse P-IVL system. One clinical trial is already underway.
Shimadzu Medical Systems USA released the latest version of its Trinias angiography system at the Radiological Society of North America (RSNA) 2022 meeting to address radiation concerns and to help improve workflow.
Christine Seidman, MD, director of the cardiovascular genetics program at Brigham & Women’s Hospital, spoke to us about using genetics to crack the code of cardiovascular disease.
A new analysis in Circulation: Cardiovascular Interventions examined rehospitalization rates after AVR, noting that they are consistently associated with worse outcomes and a higher risk of patient mortality.
A sign for reducing physician burnout at the American Medical Association (AMA) 2022 House of Delegates meeting. This has become one one of the top priorities of the AMA. Photo by Dave Fornell
A survey of nearly 6,000 cardiologists found 1 in 4 experience mental health conditions.
A 3D echo of a rheumatic mitral valve and a 2D image of the same valve showing the irregularly shaped valve opening. Images are part of the figures in the new ASE guidelines.
The American Society of Echocardiography released a new guideline document on the comprehensive use of echocardiography in the diagnosis and therapeutic intervention of rheumatic heart disease.